-
R129835-1gRaltitrexed is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth.An inhibitor of thymidylate synthase and DHFR.
-
R129835-250mgRaltitrexed is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth.An inhibitor of thymidylate synthase and DHFR.
-
R129835-50mgRaltitrexed is a thymidylate synthase inhibitor with an IC50 of 9 nM for the inhibition of L1210 cell growth.An inhibitor of thymidylate synthase and DHFR.
-
R125531-100mgRepSox is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation in cell-free assays, respectively.An ATP-competitive inhibitor of TGF-β RI kinase.
-
R125531-25mgRepSox is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation in cell-free assays, respectively.An ATP-competitive inhibitor of TGF-β RI kinase.
-
R125531-5mgRepSox is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation in cell-free assays, respectively.An ATP-competitive inhibitor of TGF-β RI kinase.
-
R613157-100μgresolvin D2.
-
-
R613158-100μgresolvin E1.
-
-
R651705-100mgRezivertinib analogue 1 is a process impurity of osimertinib mesylate. Rezivertinib analogue 1 can be used in the study of non-small cell lung cancer.Form:Solid.
-
R651705-10mgRezivertinib analogue 1 is a process impurity of osimertinib mesylate. Rezivertinib analogue 1 can be used in the study of non-small cell lung cancer.Form:Solid.